Candel Therapeutics Inc. (CADL)

AI Score

Unlock

4.57

0.04 (0.88%)

At close: Apr 17, 2025, 3:59 PM

4.74

3.71%

After-hours: Apr 17, 2025, 07:56 PM EDT

Candel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	102.65M	16.56M	21.45M	25.71M	35.41M	42.98M	51.89M	59.26M	70.06M	77.18M	86.78M	94.32M	82.64M	88.39M	24.32M	29.15M	35.05M	-45.06M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	90.11M
Long-Term Investments	n/a	n/a	n/a	266K	266K	266K	266K	n/a	266K	266K	266K	437K	424K	423K	n/a	423K	n/a	n/a
Other Long-Term Assets	329K	341K	347K	102K	116K	139K	159K	266K	266K	n/a	n/a	n/a	n/a	n/a	1.71M	937K	349K	-45.06M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.15M	1.53M	1.28M	1.42M	1.38M	2.12M	1.47M	2.62M	1.89M	1.89M	544K	1.32M	2.3M	2.56M	110K	n/a	n/a	n/a
Total Current Assets	103.8M	18.09M	22.73M	27.14M	36.8M	45.1M	53.36M	61.88M	71.94M	79.07M	87.33M	95.65M	84.94M	90.95M	24.43M	29.47M	35.15M	45.06M
Property-Plant & Equipment	2.73M	3.09M	3.4M	3.71M	4.02M	4.55M	4.92M	5.1M	5.48M	5.67M	5.71M	5.48M	3.84M	4.59M	4.61M	4.26M	2.79M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.09M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.06M	3.43M	3.75M	4.08M	4.91M	4.96M	5.35M	5.36M	5.75M	5.94M	5.97M	5.92M	4.26M	5.01M	6.32M	5.62M	3.14M	-45.06M
Total Assets	106.87M	21.52M	26.48M	31.22M	41.7M	50.06M	58.71M	67.24M	77.69M	85.01M	93.3M	101.56M	89.2M	95.96M	30.74M	35.09M	38.28M	n/a
Account Payables	237K	296K	433K	472K	422K	250K	480K	592K	380K	970K	1.58M	1.39M	1.59M	925K	759K	1.51M	921K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	108K	120K	n/a	144K	n/a	n/a	n/a	n/a	31K	63K	3.3M	3.14M	n/a
Short-Term Debt	9.89M	10.4M	10.35M	9.77M	9.41M	6.6M	3.65M	1.25M	464K	452K	440K	429K	n/a	n/a	n/a	464K	463K	n/a
Other Current Liabilities	21.72M	n/a	655K	n/a	1.83M	1.04M	2.37M	48K	1.66M	1.22M	1.23M	1M	1.68M	229K	224K	223K	187K	n/a
Total Current Liabilities	37.53M	15.27M	14M	13.54M	14.18M	10.33M	8.16M	5.24M	5.62M	5.9M	5.88M	5.47M	5.36M	4.4M	4.49M	5.5M	4.71M	n/a
Long-Term Debt	2.6M	5.07M	7.51M	9.96M	12.38M	15.06M	17.4M	19.7M	20.85M	20.75M	20.63M	20.52M	560K	541K	521K	502K	483K	n/a
Other Long-Term Liabilities	n/a	15.89M	14.25M	909K	916K	541K	1.13M	1.16M	1.88M	4.63M	5M	9.96M	19.15M	28M	19.78M	56.5M	56.52M	n/a
Total Long-Term Liabilities	3.01M	21.51M	22.46M	11.7M	14.77M	16.71M	19.77M	22.35M	24.36M	26.98M	27.35M	32.33M	19.71M	28.58M	69.42M	57.09M	57.13M	n/a
Total Liabilities	40.54M	36.77M	36.46M	25.24M	28.96M	27.04M	27.94M	27.59M	29.98M	32.88M	33.23M	37.8M	25.07M	32.97M	73.92M	62.59M	61.84M	n/a
Total Debt	13.47M	16.02M	18.56M	21.09M	22.76M	22.77M	22.78M	22.79M	22.8M	22.81M	22.8M	22.79M	560K	541K	521K	966K	946K	n/a
Common Stock	469K	322K	303K	292K	290K	290K	290K	290K	290K	290K	290K	287K	286K	286K	117K	117K	116K	n/a
Retained Earnings	-192.21M	-178.13M	-167.49M	-145.25M	-137.03M	-125.93M	-117.5M	-107.88M	-99.09M	-94.01M	-85.32M	-81.17M	-80.3M	-81.89M	-65.73M	-48.65M	-44.17M	n/a
Comprehensive Income	n/a	n/a	n/a	0.00	-0.00	0.00	0.00	n/a	-0.00	0.00	0.00	-0.00	0.00	-95.96M	-26.56M	-160K	-49.06M	-8.04M
Shareholders Equity	66.33M	-15.26M	-9.97M	5.98M	12.74M	23.02M	30.77M	39.65M	-99.09M	52.13M	60.07M	63.76M	64.14M	62.99M	-43.17M	-27.5M	-23.56M	41.02M
Total Investments	n/a	n/a	266K	266K	266K	266K	266K	n/a	266K	266K	266K	437K	424K	423K	n/a	423K	n/a	90.11M